logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Venmax Drugs Share Price

VENMAX

₹14

-0.40(-2.78%)
12th Oct 2026 | 3:17 PM
NSE :

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Venmax Drugs Share Price Today

As of 13-10-2026 07:36, Venmax Drugs & Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-14.40 (-100.00%) from the previous close of ₹14.4. The stock opened at ₹14.45 and traded between ₹13.33 and ₹14.45, with a total traded volume of 7818 shares. The company has a market capitalization of ₹12.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹31.49 and ₹12.71, respectively.

Venmax Drugs & Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 45.1, and book value of ₹1.10. Profitability indicators show ROE of 2.02%. Venmax Drugs & Pharmaceuticals Ltd. has reported revenue of ₹9.29 Cr and net profit of ₹0.28 Cr.

Venmax Drugs & Pharmaceuticals Ltd. technical indicators include Day RSI at 44.88, Day MFI at 37.29, Day ADX at 16.97. Additional indicators include Commodity Channel Index (CCI) at -136.3 and Williams %R at -62.3. Momentum indicators show Day MACD at -0.27, Day MACD Signal Line at -0.3, DayATR at 1.71. Rate of Change indicators for Venmax Drugs & Pharmaceuticals Ltd. include ROC125 at -45.24 and ROC21 at -7.88.

Exponential moving averages include EMA5 at ₹14.6, EMA10 at ₹14.7, EMA12 at ₹14.7, EMA20 at ₹14.9, EMA26 at ₹15, EMA50 at ₹15.8, EMA100 at ₹17.7, EMA200 at ₹20. Simple moving averages include SMA5 at ₹14.5, SMA10 at ₹14.9, SMA20 at ₹14.8, SMA30 at ₹14.8, SMA50 at ₹15.7, SMA100 at ₹17.8, SMA150 at ₹20.2, SMA200 at ₹21.7.

Support levels for Venmax Drugs are placed at First Support ₹13.75, Second Support ₹13.12, Third Support ₹12.75. Resistance levels are seen at First Resistance ₹14.75, Second Resistance ₹15.12, Third Resistance ₹15.75. Venmax Drugs & Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 10.46%, FII holding at 0%, DII holding at 0%, public holding at 89.53%.

Venmax Drugs Performance

Price Movement

N/A

₹13.33

₹14.45

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹14.45
Low₹13.33
Open at₹14.45
Prev Close₹14.40
Volumes7.82 K
Avg Price₹14.01
Lower Circuit₹11.52
Upper Circuit₹17.28

Historical Performance

3M High₹20.90
3M Low₹12.71
1 Yr High₹31.49
1 Yr Low₹12.71
3 Yr High₹36.96
3 Yr Low₹6.27
5 Yr High₹36.96
5 Yr Low₹6.27

Venmax Drugs Fundamentals

Market Cap
Low in industry
12.60 Cr.
PE Ratio (TTM)
Above industry Median
45.10
Dividend Yield
0
Net Profit TTM
1300.0% incr over last year
0.28
Net Profit Growth
1300.0% incr over last year
0.28
PEG Ratio
Below industry Median
0
ROE
978.3% incr over last year
2.02
Operating Revenue TTM
9.29
Operating Revenue Growth
386.4% incr over last year
Book Value
Low in industry
1.10
MFI
MFI is mid-range
37.29
RSI
RSI is mid-range
44.88
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
1.10

Venmax Drugs Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Total Revenue2.483.941.551.321.21
Operating Expense2.363.931.581.271.17
Operating Profit0.120.01-0.020.050.04
Depreciation00000
Interest00000
Tax000.010.020
Net Profit0.120.110.030.020.04

Venmax Drugs Technicals

Venmax Drugs & Pharmaceuticals Ltd. EMA & SMA

₹14.00

-0.89 (-5.98%)

↗ Bullish Moving Average

0

↘ Bearish Moving Average

16

Day EMA5 ₹14.6
Day EMA10 ₹14.7
Day EMA12 ₹14.7
Day EMA20 ₹14.9
Day EMA26 ₹15
Day EMA50 ₹15.8
Day EMA100 ₹17.7
Day EMA200 ₹20

Venmax Drugs Support and Resistance

Resistance

First Resistance₹14.75
Second Resistance₹15.12
Third Resistance₹15.75

Support

First Support₹13.75
Second Support₹13.12
Third Support₹12.75

Technical Indicators

Day RSI44.88
Day MFI37.29
Day ADX16.97
Day Commodity Channel Index-136.30
William-62.30
Day MACD-0.27
Day MACD Signal Line-0.30
Day ATR1.71
Day ROC125-45.24
Day ROC21-7.88

Venmax Drugs Shareholding Pattern

Held ByMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter23.123.123.115.113.810.5
FII000000
DII0.200000
Public76.776.976.984.986.289.5

Venmax Drugs Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.39 K2.94 K81.18%
Week3.35 K4.2 K79.64%
1 Month11.54 K14.15 K81.53%
6 Month5.34 K6.42 K83.16%

Venmax Drugs SWOT Analysis

Strengths13
Weakness11
Opportunity0
Threats0

Consistent high performing stocks over Five Years

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Biggest Price Gainers from Open

Venmax Drugs Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Venmax Drugs Stock Comparison

Financials
Price (₹)₹112.65₹150₹32.50₹504.05₹168.45₹290
% Change-3.43%-1.96%0.00%2.06%-0.03%0.00%
Revenue TTM (₹ Cr)---₹526.28--
Net Profit TTM (₹ Cr)---₹20.77--
PE TTM14.6016.407.70106.5012.8043.30
1 Year Return11.5127.67
ROCE-34.19-3.56--
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on VENMAX

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy